Novavax (NVAX) IV at 133 into developing Covid-19 vaccine
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
- Nasdaq notches record high close as investors focus on earnings
- Oil slips on rising Mideast crude exports, G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
Tweet
Share
E-mail
Get Alerts NVAX Hot Sheet
Join SI Premium – FREE
Novavax (NASDAQ: NVAX) 30-day option implied volatility is at 133; compared to its 52-week range of 85 to 312 into developing Covid-19 vaccine.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- PowerShares QQQ Trust (QQQ) call put ratio 1 call to 1.5 puts as share price near all-time high
- Market Vectors Oil Services ETF (OIH) call put ratio 1 call to 1.3 puts amid energy price movement
- United States Oil Fund (USO) call put ratio 1 call to 1.5 puts amid energy price movement
Create E-mail Alert Related Categories
OptionsRelated Entities
OptionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
